Denali Therapeutics Stock Forecast

Buy or Hold candidate since Jun 09, 2026 Gain 1.11%

The Denali Therapeutics Inc. stock price gained 1.99% on the last trading day (Thursday, 11th Jun 2026), rising from $20.61 to $21.02. During the last trading day the stock fluctuated 6.46% from a day low at $20.37 to a day high of $21.69. The price has risen in 6 of the last 10 days and is up by 0.33% over the past 2 weeks. Volume fell on the last day by -481 thousand shares and in total, 2 million shares were bought and sold for approximately $40.34 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $21.37 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -2.25% during the next 3 months and, with a 90% probability hold a price between $17.28 and $20.89 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

DNLI Signals & Forecast

The Denali Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $20.18 and $19.57. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -0.0951%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Denali Therapeutics Inc. stock

Denali Therapeutics Inc. finds support from accumulated volume at $20.57 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.32 between high and low, or 6.46%. For the last week, the stock has had daily average volatility of 5.97%.

Our recommended stop-loss: $20.33 (-3.30%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (DNLI) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect Denali Therapeutics Inc. to open at $21.03, and during the day (based on 14 day Average True Range), to move between $20.48 and $21.56, which gives a possible trading interval of +/-$1.08 (+/-5.27%) up or down from last closing price. If Denali Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $21.09 (0.33%) than the support at $20.57 (2.14%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Denali Therapeutics Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.451 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $21.03 ( 0.0238%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk